Cargando…
Topical and Conventional Systemic Treatments in Atopic Dermatitis: Have They Gone Out of Fashion?
Atopic dermatitis is a Th2 disease, due to relapse of IL-4 and IL-13 by Th2 cells. Despite the approval by FDA of dupilumab, the first monoclonal antibody for the severe forms, traditional drugs remain a milestone for the treatment of this dermatosis. Dermatologists need a good knowledge of all ther...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mattioli 1885
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824598/ https://www.ncbi.nlm.nih.gov/pubmed/35223191 http://dx.doi.org/10.5826/dpc.1201a155 |